Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Baigent

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|March 22, 2017
Safety and efficacy of statins - Authors' replyRory Collins, Jane Armitage, Colin Baigent, et al.
Lancet (London, England)|March 11, 2015
Alemtuzumab induction therapy in kidney transplantation - Authors' replyRichard Haynes, Colin Baigent, Martin J Landray, et al.
Lancet (London, England)|June 11, 2026
Challenges in assessing statin-associated adverse events - Authors' replyChristina Reith, Jonathan R Emberson, David Preiss, et al.
Plos One|November 1, 2011
Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysisMarion Mafham, Jonathan Emberson, Martin J Landray, et al.
Seminars in Dialysis|July 22, 2014
Evidence for the prevention and treatment of stroke in dialysis patientsWilliam Herrington, Richard Haynes, Natalie Staplin, et al.
European Journal of Preventive Cardiology|February 13, 2021
Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society SurveyKonstantinos C Koskinas, Alberico L Catapano, Colin Baigent, et al.
Lancet (London, England)|March 2, 2024
Ambulatory blood pressure monitoring and mortality - Authors' replyAlejandro de la Sierra, Natalie Staplin, Luis M Ruilope, et al.
Lancet (London, England)|April 20, 2015
Thrombolysis in acute stroke--authors' replyJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
Clinical Trials (London, England)|February 20, 2008
Ensuring trial validity by data quality assurance and diversification of monitoring methodsColin Baigent, Frank E Harrell, Marc Buyse, et al.
The New England Journal of Medicine|September 4, 2008
Analyses of cancer data from three ezetimibe trialsRichard Peto, Jonathan Emberson, Martin Landray, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|March 22, 2017
Safety and efficacy of statins - Authors' replyRory Collins, Jane Armitage, Colin Baigent, et al.
Lancet (London, England)|March 11, 2015
Alemtuzumab induction therapy in kidney transplantation - Authors' replyRichard Haynes, Colin Baigent, Martin J Landray, et al.
Lancet (London, England)|June 11, 2026
Challenges in assessing statin-associated adverse events - Authors' replyChristina Reith, Jonathan R Emberson, David Preiss, et al.
Plos One|November 1, 2011
Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysisMarion Mafham, Jonathan Emberson, Martin J Landray, et al.
Seminars in Dialysis|July 22, 2014
Evidence for the prevention and treatment of stroke in dialysis patientsWilliam Herrington, Richard Haynes, Natalie Staplin, et al.
European Journal of Preventive Cardiology|February 13, 2021
Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society SurveyKonstantinos C Koskinas, Alberico L Catapano, Colin Baigent, et al.
Lancet (London, England)|March 2, 2024
Ambulatory blood pressure monitoring and mortality - Authors' replyAlejandro de la Sierra, Natalie Staplin, Luis M Ruilope, et al.
Lancet (London, England)|April 20, 2015
Thrombolysis in acute stroke--authors' replyJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
Clinical Trials (London, England)|February 20, 2008
Ensuring trial validity by data quality assurance and diversification of monitoring methodsColin Baigent, Frank E Harrell, Marc Buyse, et al.
The New England Journal of Medicine|September 4, 2008
Analyses of cancer data from three ezetimibe trialsRichard Peto, Jonathan Emberson, Martin Landray, et al.
Pageof 18